NP90323(b) Botulinum Toxin Type A Medicines (Dysport®)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-0407c432014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
17 Nov 2023
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Information Technology Service Management | contract | — | 08 May 2026 |
| Patient Carer Online Feedback Service | contract | — | 08 May 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 30 Mar 2026 |
| NP884925 Adobe Licence | contract | — | 27 Mar 2026 |
| Automated AST & Bacteria Testing | contract | — | 27 Mar 2026 |
| Sampling & Measuring Products | contract | — | 25 Mar 2026 |
| NP90726l Tildrakizumab (Ilumetri®) | contract | — | 17 Mar 2026 |
| Ophthalmology Equipment | contract | £8.0m | 11 Mar 2026 |
| Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables | contract | £100.0m | 11 Mar 2026 |
| Single Use Podiatry Instruments | contract | £2.0m | 11 Mar 2026 |
Other contracts awarded to Ipsen Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Triptorelin (Decapeptyl®) | contract | — | 01 Dec 2025 |
| Triptorelin (Decapeptyl®) | contract | — | 05 Nov 2025 |
| Proprietary Drugs | contract | — | 28 Jul 2025 |
| Medicinal Products and Pharma Funded Homecare [5749446] | contract | — | 17 Jun 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 | contract | — | 22 Apr 2025 |
| NP39724 Generic and Biosimilar Cancer Medicines | contract | — | 27 Feb 2025 |
| NP90219c Triptorelin (Decapeptyl®) | contract | — | 05 Nov 2024 |
| NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 | contract | £17.6m | 26 Feb 2024 |
| Gonadorelin Analogues | contract | — | 09 Nov 2023 |
| NP90323(b) Botulinum Toxin Type A Medicines (Dysport®) | contract | — | 04 Oct 2023 |